439 related articles for article (PubMed ID: 11027469)
1. Role of platelet-activating factor in leukocyte-independent plasma extravasation and mast cell activation during endotoxemia.
Walther A; Yilmaz N; Schmidt W; Bach A; Gebhard MM; Martin E; Schmidt H
J Surg Res; 2000 Oct; 93(2):265-71. PubMed ID: 11027469
[TBL] [Abstract][Full Text] [Related]
2. Methysergide attenuates leukocyte-independent plasma extravasation during endotoxemia.
Walther A; Yilmaz N; Schmidt W; Bach A; Gebhard MM; Martin E; Schmidt H
J Crit Care; 2001 Sep; 16(3):121-6. PubMed ID: 11689769
[TBL] [Abstract][Full Text] [Related]
3. Effects of histamine-1 receptor antagonism on leukocyte-independent plasma extravasation during endotoxemia.
Walther A; Jäger M; Secchi A; Schmidt W; Bach A; Martin E; Schmidt H
J Crit Care; 2001 Mar; 16(1):24-31. PubMed ID: 11230721
[TBL] [Abstract][Full Text] [Related]
4. Role of antithrombin and factor XIII in leukocyte-independent plasma extravasation during endotoxemia: an intravital-microscopic study in the rat.
Czabanka M; Martin E; Walther A
J Surg Res; 2006 Dec; 136(2):219-26. PubMed ID: 16457847
[TBL] [Abstract][Full Text] [Related]
5. Influence of the platelet-activating factor receptor antagonist BN52021 on endotoxin-induced leukocyte adherence in rat mesenteric venules.
Schmidt H; Ebeling D; Bauer H; Bŏhrer H; Gebhard MM; Martin E
J Surg Res; 1996 Jan; 60(1):29-35. PubMed ID: 8592427
[TBL] [Abstract][Full Text] [Related]
6. Leukocyte-independent plasma extravasation during endotoxemia.
Walther A; Weihrauch M; Schmidt W; Gebhard MM; Martin E; Schmidt H
Crit Care Med; 2000 Aug; 28(8):2943-8. PubMed ID: 10966276
[TBL] [Abstract][Full Text] [Related]
7. Rapid mast cell activation causes leukocyte-dependent and -independent permeability alterations.
Kubes P; Gaboury JP
Am J Physiol; 1996 Dec; 271(6 Pt 2):H2438-46. PubMed ID: 8997303
[TBL] [Abstract][Full Text] [Related]
8. Role of platelet-activating factor in ischemia/reperfusion-induced leukocyte adherence.
Kubes P; Ibbotson G; Russell J; Wallace JL; Granger DN
Am J Physiol; 1990 Aug; 259(2 Pt 1):G300-5. PubMed ID: 2166441
[TBL] [Abstract][Full Text] [Related]
9. Role of nitric oxide in leukocyte-independent endothelial damage during experimental endotoxemia.
Walther A; Barth C; Gebhard MM; Martin E
Shock; 2003 Sep; 20(3):286-91. PubMed ID: 12923503
[TBL] [Abstract][Full Text] [Related]
10. Influence of lidocaine on endotoxin-induced leukocyte-endothelial cell adhesion and macromolecular leakage in vivo.
Schmidt W; Schmidt H; Bauer H; Gebhard MM; Martin E
Anesthesiology; 1997 Sep; 87(3):617-24. PubMed ID: 9316968
[TBL] [Abstract][Full Text] [Related]
11. Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia.
László F; Whittle BJ; Moncada S
Br J Pharmacol; 1994 Dec; 113(4):1131-6. PubMed ID: 7889265
[TBL] [Abstract][Full Text] [Related]
12. N-acetylcysteine attenuates endotoxin-induced leukocyte-endothelial cell adhesion and macromolecular leakage in vivo.
Schmidt H; Schmidt W; Müller T; Böhrer H; Gebhard MM; Martin E
Crit Care Med; 1997 May; 25(5):858-63. PubMed ID: 9187607
[TBL] [Abstract][Full Text] [Related]
13. Platelet activating factor receptor antagonist improves survival and attenuates eicosanoid release in severe endotoxemia.
Fletcher JR; DiSimone AG; Earnest MA
Ann Surg; 1990 Mar; 211(3):312-6. PubMed ID: 2178565
[TBL] [Abstract][Full Text] [Related]
14. C1-esterase inhibitor and its effects on endotoxin-induced leukocyte adherence and plasma extravasation in postcapillary venules.
Schmidt W; Stenzel K; Gebhard MM; Martin E; Schmidt H
Surgery; 1999 Mar; 125(3):280-7. PubMed ID: 10076612
[TBL] [Abstract][Full Text] [Related]
15. A PAF receptor antagonist, BN 52021, attenuates thromboxane release and improves survival in lethal canine endotoxemia.
Moore JM; Earnest MA; DiSimone AG; Abumrad NN; Fletcher JR
Circ Shock; 1991 Sep; 35(1):53-9. PubMed ID: 1660355
[TBL] [Abstract][Full Text] [Related]
16. Effect of the 21-aminosteroid tirilazad mesylate on leukocyte adhesion and macromolecular leakage during endotoxemia.
Schmidt H; Schmidt W; Müller T; Böhrer H; Bach A; Gebhard MM; Martin E
Surgery; 1997 Mar; 121(3):328-34. PubMed ID: 9068675
[TBL] [Abstract][Full Text] [Related]
17. Influence of N-acetylcysteine treatment on endotoxin-induced microcirculatory disturbances.
Schmidt W; Walther A; Gebhard MM; Martin E; Schmidt H
Intensive Care Med; 1998 Sep; 24(9):967-72. PubMed ID: 9803334
[TBL] [Abstract][Full Text] [Related]
18. Cytidine-5-diphosphocholine reduces microvascular permeability during experimental endotoxemia.
Schmidt K; Hernekamp JF; Doerr M; Zivkovic AR; Brenner T; Walther A; Weigand MA; Hofer S
BMC Anesthesiol; 2015 Aug; 15():114. PubMed ID: 26232247
[TBL] [Abstract][Full Text] [Related]
19. Glycoprotein IIB/IIIA-inhibition and microcirculatory alterations during experimental endotoxemia--an intravital microscopic study in the rat.
Walther A; Czabanka M; Gebhard MM; Martin E
Microcirculation; 2004; 11(1):79-88. PubMed ID: 15280099
[TBL] [Abstract][Full Text] [Related]
20. Mesenteric microvascular inflammatory responses to systemic hypoxia are mediated by PAF and LTB4.
Casillan AJ; Gonzalez NC; Johnson JS; Steiner DR; Wood JG
J Appl Physiol (1985); 2003 Jun; 94(6):2313-22. PubMed ID: 12598480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
